Psyence Biomedical (PBM) Interest Expenses (2023 - 2025)
Psyence Biomedical's (PBM) quarterly Interest Expenses came in at -$2753.0 in Q3 2025, down 174.1% year-on-year from $3715.0 in Q3 2024, and down 174.1% quarter-over-quarter from $3715.0 in Q3 2024.
Psyence Biomedical (PBM) Interest Expenses (2023 - 2025) Analysis & Trends
Psyence Biomedical's Interest Expenses history runs 3 years deep, the most recent figure standing at -$2753.0 for Q3 2025.
- On a quarterly basis, Interest Expenses fell 174.1% year-over-year to -$2753.0 in Q3 2025; TTM through Mar 2026 was $962.0, a 103.97% increase from a year earlier, with the FY2026 full-year figure at $9522.0, up 2.72% from the prior year.
- Interest Expenses eased to -$2753.0 in Q3 2025 per PBM's latest filing, from $3715.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $3715.0 in Q3 2024 and bottomed at -$27936.0 in Q3 2023.
- The 3-year median for Interest Expenses is -$2753.0 (2025), against an average of -$8991.3.
- Across the five-year window, Interest Expenses jumped 113.3% in 2024 and sank 174.1% in 2025, its largest moves.
- Year by year, Interest Expenses stood at -$27936.0 in 2023, then surged by 113.3% to $3715.0 in 2024, then plunged by 174.1% to -$2753.0 in 2025.
- Per Business Quant, the three latest PBM Interest Expenses figures stand at -$2753.0 (Q3 2025), $3715.0 (Q3 2024), and -$27936.0 (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Psyence Biomedical | 1.56 Mn | 1.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,753.00 |
| Sep 30, 2025 | -2,753.00 |
| Sep 30, 2024 | 3,715.00 |
| Sep 30, 2024 | 3,715.00 |
| Sep 30, 2023 | -27,936.00 |
| Sep 30, 2023 | -27,936.00 |